002173.SHE Innovative Medical Management Co Ltd
- Market cap
- CNY 7.60B
- P/E
- -
- P/B
- 4.69x
- ROE
- -6.7%
- Dividend yield
- 0.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002173.SHE undervalued?
Graham numberThe Graham number of Innovative Medical Management Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Innovative Medical Management Co Ltd fundamental analysis
No fundamental analysis for Innovative Medical Management Co Ltd yet.
Innovative Medical Management Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Innovative Medical Management Co Ltd
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. It also offers outpatient, inpatient, rehabilitation services, and medical examination services. In addition, it offers supply chain management and procurement of pharmaceuticals, medical consumables, and equipment. The company was formerly known as Qianzu Pearl Group Co., Ltd. and c…
Full company profileInnovative Medical Management Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Innovative Medical Management Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 763M | 841M | 1.01B | 872M | 724M | 712M | 710M | 806M | 816M | 781M | 683M |
| Gross Profit | 295M | 353M | 394M | 69.1M | 26.0M | 47.4M | 30.2M | 91.6M | 63.5M | 54.0M | 8.95M |
| Operating Income | 166M | 236M | 123M | -1.06B | -217M | -56.4M | -78.6M | -25.6M | -60.3M | -69.7M | -111M |
| EBITDA | 275M | 314M | 304M | -19.5M | 190K | 30.9M | 8.77M | 56.9M | 23.0M | 70.9M | -110M |
| Net Income | 115M | 141M | 29.7M | -1.15B | -315M | -103M | -73.4M | -34.3M | -94.0M | -34.9M | -108M |
| EPS | 0.26 | 0.31 | 0.07 | -2.53 | -0.69 | -0.23 | -0.16 | -0.08 | -0.21 | -0.08 | -0.25 |
| Balance Sheet | |||||||||||
| Total Assets | 4.57B | 4.65B | 4.27B | 2.97B | 2.68B | 2.56B | 2.34B | 2.28B | 2.20B | 2.18B | 1.99B |
| Total Liabilities | 1.04B | 994M | 649M | 498M | 533M | 565M | 434M | 410M | 427M | 415M | 365M |
| Shareholders' Equity | 3.53B | 3.66B | 3.62B | 2.47B | 2.14B | 1.99B | 1.90B | 1.87B | 1.78B | 1.75B | 1.62B |
| Cash & Short-term Investments | 1.33B | 561M | 618M | 941M | 940M | 800M | 658M | 583M | 426M | 328M | 307M |
| Total Debt | 348M | 308M | 361M | 95.6M | 61.5M | 63.8M | 58.4M | 68.5M | 64.2M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 250M | 206M | 129M | 96.4M | 132M | 43.4M | -24.4M | 11.0M | -7.34M | 75.9M | - |
| Capital Expenditure | 181M | 165M | 400M | 160M | 108M | 111M | 123M | 96.2M | 47.0M | 84.5M | 21.4M |
| Free Cash Flow | 69.2M | 41.5M | -270M | -64.1M | 23.3M | -67.4M | -148M | -85.2M | -54.3M | -8.59M | -40.3M |
| Ratios | |||||||||||
| ROE | 3.2% | 3.9% | 0.8% | -46.6% | -14.7% | -5.2% | -3.9% | -1.8% | -5.3% | -2.0% | -6.7% |
| ROA | 2.5% | 3.0% | 0.7% | -38.7% | -11.7% | -4.0% | -3.1% | -1.5% | -4.3% | -1.6% | -5.4% |
| Net Profit Margin | 15.0% | 16.7% | 2.9% | -131.9% | -43.4% | -14.5% | -10.3% | -4.3% | -11.5% | -4.5% | -15.9% |
| Debt to Equity | 0.10x | 0.08x | 0.10x | 0.04x | 0.03x | 0.03x | 0.03x | 0.04x | 0.04x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Innovative Medical Management Co Ltd dividends
- Dividend yield
- 0.03%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 25, 2018
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 2.59M | 0.01 | - |
| 2024 | CNY 2.59M | 0.01 | - |
| 2023 | CNY 1.46M | 0.00 | - |
| 2022 | CNY 795K | 0.00 | - |
| 2021 | CNY 2.35M | 0.01 | - |
| 2020 | CNY 3.72M | 0.01 | - |
| 2019 | CNY 11.9M | 0.03 | - |
| 2018 | CNY 64.5M | 0.15 | 217.4% |
| 2017 | CNY 14.7M | 0.03 | 10.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on May 6, 2011.
Who owns Innovative Medical Management Co Ltd
- Insiders 27.53%
- Institutions 0.54%
- Public & others 71.93%
- Shares outstanding 441M
- Free float 312M
Innovative Medical Management Co Ltd company profile
- Company name
- Innovative Medical Management Co Ltd
- Ticker
- 002173.SHE
- ISIN
- CNE1000007J6
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Sep 28, 2007
- Sector
- Consumer Cyclical
- Industry
- Health Care Providers & Services
- Employees
- 2,572
- Fiscal year end
- December
- Address
- Zhengjiahu Village, Zhuji, China, 311804
- Phone
- 86 575 87160891
- Website
- chxyl.com
About Innovative Medical Management Co Ltd
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. It also offers outpatient, inpatient, rehabilitation services, and medical examination services. In addition, it offers supply chain management and procurement of pharmaceuticals, medical consumables, and equipment. The company was formerly known as Qianzu Pearl Group Co., Ltd. and changed its name to Innovative Medical Management Co.,Ltd. in June 2016. Innovative Medical Management Co.,Ltd. was founded in 2003 and is headquartered in Zhuji, China.
Innovative Medical Management Co Ltd management
2- Mr. Jianjian MaPresident & Director · born 1965
- Ms. Lidan GuoBoard Secretary · born 1992